Scottsdale Office : 9989 N
The SURMOUNT-1 trial showed tirzepatide at its highest dose produced 22.5% weight loss over 72 weeks
Implications of the era of incretin-based weight loss therapy in menopause
Another analysis of 12 studies found that people who took alpha-lipoic acid lost an average of 2.8 pounds (1.27 kg) more than those taking a placebo over an average of 23 weeks ( In short, it seems that alpha-lipoic acid has just a slight effect on weight loss in humans
S., Kubow, S., Grey, V., Riverin, V., & Lands, L
As a GLP-1 receptor agonist, it regulates appetite and improves blood sugar control, making it suitable for those with obesity or related health issues